Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Longitudinal Study

被引：0
|
作者：
Gaurav, R.
Yahia-Cherif, L.
Mangone, G.
Pyatigorskaya, N.
Valabregue, R.
Ewenczyk, C.
Hutchison, M.
Corvol, J.
Vidailhet, M.
Lehericy, S.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1890
引用
收藏
页码：S789 / S790
页数：2
相关论文
共 50 条
  • [21] Significance of neuromelanin for neurodegeneration in Parkinson's disease
    Double, KL
    Riederer, P
    Gerlach, M
    DRUG NEWS & PERSPECTIVES, 1999, 12 (06) : 333 - 340
  • [22] Imaging Proton Spin Density as a Means to Map Neuromelanin: A Novel Approach for Neuromelanin Sensitive MRI in Parkinson's Disease
    Liu, Peng
    He, Naying
    Wang, Xinhui
    Zhang, Youmin
    LeWitt, Peter
    Yan, Fuhua
    Haacke, E. Mark
    MOVEMENT DISORDERS, 2022, 37 : S13 - S14
  • [23] Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis
    Xing, Yue
    Sapuan, Abdul Halim
    Martin-Bastida, Antonio
    Naidu, Saadnah
    Tench, Christopher
    Evans, Jonathan
    Sare, Gillian
    Schwarz, Stefan T.
    Al-Bachari, Sarah
    Parkes, Laura M.
    Kanavou, Sofia
    Raw, Jason
    Silverdale, Monty
    Bajaj, Nin
    Pavese, Nicola
    Burn, David
    Piccini, Paola
    Grosset, Donald G.
    Auer, Dorothee P.
    MOVEMENT DISORDERS, 2022, 37 (05) : 1028 - 1039
  • [24] Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study
    Laurencin, Chloe
    Lancelot, Sophie
    Brosse, Sarah
    Merida, Ines
    Redoute, Jerome
    Greusard, Elise
    Lamberet, Ludovic
    Liotier, Veronique
    Le Bars, Didier
    Costes, Nicolas
    Thobois, Stephane
    Boulinguez, Philippe
    Ballanger, Benedicte
    BRAIN, 2024, 147 (04) : 1377 - 1388
  • [25] Longitudinal Dosing Changes for Parkinson's Disease
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 15 - 15
  • [26] Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study
    Sommerauer, Michael
    Fedorova, Tatyana D.
    Hansen, Allan K.
    Knudsen, Karoline
    Otto, Marit
    Jeppesen, Jesper
    Frederiksen, Yoon
    Blicher, Jakob U.
    Geday, Jacob
    Nahimi, Adjmal
    Damholdt, Malene F.
    Brooks, David J.
    Borghammer, Per
    BRAIN, 2018, 141 : 496 - 504
  • [27] An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI
    Liu, Qiang
    Wang, Pan
    Liu, Chenghe
    Xue, Feng
    Wang, Qian
    Chen, Yuqing
    Hou, Ruihua
    Chen, Teng
    BMC NEUROLOGY, 2023, 23 (01)
  • [28] Longitudinal brain structure changes in Parkinson's disease: A replication study
    Sokolowski, Andrzej
    Bhagwat, Nikhil
    Chatelain, Yohan
    Dugre, Mathieu
    Hanganu, Alexandru
    Monchi, Oury
    McPherson, Brent
    Wang, Michelle
    Poline, Jean-Baptiste
    Sharp, Madeleine
    Glatard, Tristan
    PLOS ONE, 2024, 19 (01):
  • [29] Anthropometric Changes in Parkinson's Disease: Canadian Longitudinal Study on Aging
    Zolfaghari, S.
    Pelletier, A.
    Postuma, R.
    MOVEMENT DISORDERS, 2022, 37 : S647 - S647
  • [30] Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease
    Baba, Toru
    Hosokai, Yoshiyuki
    Nishio, Yoshiyuki
    Kikuchi, Akio
    Hirayama, Kazumi
    Suzuki, Kyoko
    Hasegawa, Takafumi
    Aoki, Masashi
    Takeda, Atsushi
    Mori, Etsuro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 372 : 288 - 293
12345